Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Bowman Consulting Group Q1 2026 Earnings Call - Record backlog and upgraded guidance as energy and data center work accelerate
Bowman kicked off 2026 with a punch. Q1 produced double-digit growth in gross contract revenue, net service billing, and Adjusted EBITDA, and backlog hit a record of about $653 million. Management rai...
- Record backlog reached approximately $653 million, up 56% year-over-year and 36% sequentially, driven entirely by organic wins in the quarter.
- Management raised full-year 2026 guidance to $520 million to $540 million in net revenue and now targets Adjusted EBITDA margin of 17.25% to 17.75%.
- Q1 gross contract revenue was $126.5 million, a 12% increase versus prior year; Net service billing was $114.2 million, up 14% year-over-year at a ~90% net-to-gross ratio.
- +12 more takeaways
Gulfport Energy Corporation Q1 2026 Earnings Call - Record buybacks and acreage build while leverage stays below 1x
Gulfport kicked off 2026 by buying assets and buying back stock, and the numbers back the headline. First quarter adjusted EBITDA was $264 million, adjusted free cash flow $119 million, and pro forma ...
- New CEO announced: Domenic J. Dell'Osso, Jr. will join as President and Chief Executive Officer effective May 28, bringing industry experience and focus on operational and financial discipline.
- Strong Q1 financials: adjusted EBITDA $264 million, adjusted free cash flow $119 million.
- Production and guidance: Q1 average production 997 Mcfe/d, reaffirmed full-year 2026 guidance of 1.03 to 1.055 Bcfe/d.
- +16 more takeaways
The Brink’s Company Q1 2026 Earnings Call - AMS/DRS Momentum Validates Atleos Buy to Shift Mix and Lift Margins
Brink’s reported a solid Q1 2026, with revenue up 10% year over year and adjusted EBITDA of $238 million, driven by continued strength in higher‑margin ATM Managed Services and Digital Retail Solution...
- Revenue rose 10% year over year in Q1 2026, with management citing roughly 4.5% organic growth and CFO reporting 5% constant currency growth with a favorable FX impact.
- Adjusted EBITDA was $238 million, a 10% increase year over year, and margin expanded about 10 basis points to 17.3% for the quarter.
- Trailing twelve‑month EBITDA reached $1.0 billion for the first time in company history, up more than $200 million since end of 2022.
- +15 more takeaways
Sixth Street Specialty Lending, Inc. Q1 2026 Earnings Call - Cuts Base Dividend to $0.42 After Spread-Driven NAV Marks, Positions to Deploy Capital into Wider-Spread Opportunities
Q1 was a market-mark quarter, not a credit-loss quarter. Sixth Street reported NII of $0.42 per share (annualized ROE 9.9%) but a GAAP net loss of $0.27 per share driven by $0.58 of unrealized fair va...
- Net investment income of $0.42 per share produced an annualized ROE of 9.9% for Q1 2026, but reported net loss per share was $0.27 due to unrealized marks.
- NAV per share fell about 4.3% to $16.24 at quarter end, with $0.58 per share (nearly 80% of the decline) attributable to fair value inputs driven by wider market credit spreads and lower equity multiples.
- Of the $0.58 fair value impact, $0.40 per share came from debt portfolio marks (spread widening) and $0.18 per share from lower valuations in the limited equity portfolio.
- +16 more takeaways
Azenta Q2 2026 Earnings Call - Guidance Reset After Multiomics Weakness and Store Quality Headwinds
Azenta reported a disappointing Q2, with organic revenue down 3% and adjusted EBITDA margin compressed to 5.4% as execution gaps and a cautious capital environment in North America hit volumes. Manage...
- Reported Q2 revenue $145 million, up 1% reported, down 3% organically excluding UK Biocentre and FX impact.
- Adjusted EBITDA was $7.8 million, or 5.4% of revenue, down 320 basis points year-over-year.
- Management said they are not satisfied with results, citing execution shortcomings that were within their control and a cautious, prolonged demand environment in North America.
- +13 more takeaways
Limbach Holdings Q1 2026 Earnings Call - Strong Bookings and Data Center Momentum, Near-Term Margin Drag from Pioneer
Limbach reported Q1 2026 revenue of $138.9 million, broadly in line with prior guidance, even as organic revenue declined due to a soft middle of 2025 bookings cadence and normal seasonality. The quar...
- Total Q1 2026 revenue $138.9 million, up 4.3% year-over-year, but total organic revenue down 13.4% as expected due to weaker bookings mid-2025 and seasonal industrial patterns.
- Q1 bookings were $209 million, producing a 1.5 book-to-bill; combined with Q4 2025, the last two quarters yielded over $434 million in bookings, evidence of accelerating demand.
- About 27% of Q1 bookings came from data center opportunities, underscoring management’s push into hyperscaler and mission-critical verticals and faster-converting fabrication-style projects.
- +12 more takeaways
Spire Inc. Q2 2026 Earnings Call - Portfolio Clean Up Funds Tennessee Buy, Weather Shock Creates Near-Term Margin Shortfall
Spire used a fast, surgical set of transactions to fund and close the Piedmont Tennessee acquisition, moving the company to a simpler, fully regulated utility footprint without issuing equity. Managem...
- Spire reported Q2 adjusted continuing operations EPS of $3.76, up from $3.17 a year ago, with adjusted earnings of $224 million for the quarter.
- Management closed the Piedmont Tennessee acquisition on March 31, adding over 200,000 customers in the fast-growing Nashville region, and completed integration planning including an 18-month transition services agreement.
- The Tennessee purchase was funded without issuing common equity, using a financing mix that includes $900 million of junior subordinated notes, $825 million of Spire Tennessee senior notes, proceeds from recent asset sales, and an $800 million term loan bridge until those proceeds arrive.
- +16 more takeaways
International General Insurance Holdings Ltd First Quarter 2026 Earnings Call - Strong Q1 Execution Despite Middle East Losses, Political Violence Seen as Pricing Opportunity
IGI reported a resilient start to 2026, delivering underwriting income of $37.7 million and a combined ratio of 89.1% despite sizeable losses tied to the Middle East conflict. Management emphasized di...
- Gross written premium was $197.2 million, down 4.5% year over year, reflecting deliberate cycle management and two non-renewed reinsurance programs.
- Underwriting income jumped 35.1% to $37.7 million, producing a first quarter combined ratio of 89.1%, 5.3 points better than Q1 2025 and in line with long-term averages.
- The quarter included about $15 million of net losses tied to the Middle East conflict, reflected mainly in the political violence book and an energy loss in the Persian Gulf.
- +14 more takeaways
United Therapeutics Q1 2026 Earnings Call - Ralinepag and TYVASO clinical wins set stage for multi-billion revenue surge
United Therapeutics reported $782 million in Q1 2026 revenue, driven by TYVASO sales of $458 million, while management flagged two clinical readouts that they say change the company’s trajectory. ADVA...
- Q1 2026 revenue was $782 million, with TYVASO sales of $458 million.
- Seasonality, severe winter weather and pharmacy operations issues slowed patient starts in Q1, but management expects sequential growth to resume.
- ADVANCE OUTCOMES top-line results for oral ralinepag showed a threefold reduction in disease progression versus background therapy and durable benefit through four years, per management.
- +13 more takeaways
GXO Q1 2026 Earnings Call - Raises 2026 EBITDA and EPS on Record $2.7B Pipeline and AI/Automation Scale-up
GXO came out of the gates strong in Q1 2026, reporting $3.3 billion in revenue, adjusted EBITDA of $200 million and adjusted EPS of $0.50, each materially ahead year-over-year. Management raised full-...
- Q1 results: Revenue $3.3 billion, up 10.8% year-over-year; adjusted EBITDA $200 million, up 22.7%; adjusted diluted EPS $0.50, up 72.4%.
- Organic revenue growth of 4.1% in Q1, management expects similar growth in Q2 with acceleration in the back half of 2026.
- Guidance raised: full-year adjusted EBITDA to $935 million to $975 million, adjusted diluted EPS to $2.90 to $3.20, representing ~22% EPS growth at the midpoint; organic revenue growth maintained at 4% to 5%.
- +12 more takeaways